GINS2 and acute myeloid leukemia: Then, the differences in GINS2 expression in adrenocortical carcinoma (ACC), lymphoid neoplasm diffuse large B cell lymphoma (DLBC), acute myeloid leukemia (LAML), brain lower grade glioma (LGG), ovarian serous cystadenocarcinoma (OV), sarcoma (SARC), cutaneous skin melanoma (SKCM), thymoma (THYM), and uterine carcinosarcoma (UCS) from that in normal tissue were evaluated.